Comedonecrosis within conventional prostatic adenocarcinoma vs. intraductal carcinoma of the prostate: their clinical significance is not comparable

Wang, Ying; Teramoto, Yuki; Miyamoto, Hiroshi

doi:10.1016/j.humpath.2023.06.011

Human Pathology

2023

DOI: 10.1016/j.humpath.2023.06.011

|View full text |Cite

Comedonecrosis within conventional prostatic adenocarcinoma vs. intraductal carcinoma of the prostate: their clinical significance is not comparable

Ying Wang,

Yuki Teramoto,

Hiroshi Miyamoto

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Cribriform intraductal carcinoma of the prostate may be more aggressive than cribriform conventional/acinar prostatic adenocarcinoma

Wang,

Teramoto,

Miyamoto

2024

Pathology

View full text Add to dashboard Cite

Cribriform intraductal carcinoma of the prostate may be more aggressive than cribriform conventional/acinar prostatic adenocarcinoma

Wang,

Teramoto,

Miyamoto

2024

Pathology

View full text Add to dashboard Cite

Cribriform intraductal carcinoma of the prostate may be more aggressive than cribriform conventional/acinar prostatic adenocarcinoma: counterintuitive finding needs validation

Varma,

van der Kwast

2024

Pathology

View full text Add to dashboard Cite

Intraductal carcinoma of the prostate: conflicting recommendations confuse clinicians

Varma,

Berney,

Kristiansen

et al. 2024

J Clin Pathol

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Comedonecrosis within conventional prostatic adenocarcinoma vs. intraductal carcinoma of the prostate: their clinical significance is not comparable

Cited by 3 publications

References 18 publications

Cribriform intraductal carcinoma of the prostate may be more aggressive than cribriform conventional/acinar prostatic adenocarcinoma

Cribriform intraductal carcinoma of the prostate may be more aggressive than cribriform conventional/acinar prostatic adenocarcinoma

Cribriform intraductal carcinoma of the prostate may be more aggressive than cribriform conventional/acinar prostatic adenocarcinoma: counterintuitive finding needs validation

Intraductal carcinoma of the prostate: conflicting recommendations confuse clinicians

Contact Info

Product

Resources

About